Expert opinion on mexiletine treatment in adult patients with myotonic dystrophy
2024 · Archives of cardiovascular diseases · 6 citations
https://doi.org/10.1016/j.acvd.2024.03.001
J
Jean‐Marc Sellal
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
128
Papers
2.2K
Citations
21
h-index
35
i10-index
Jean‐Marc Sellal is an academic researcher from Inserm. The author has contributed to research in topics: Cardiac Arrhythmias and Treatments & Atrial Fibrillation Management and Outcomes & Cardiac electrophysiology and arrhythmias. The author has an h-index of 21, co-authored 109 publications.
ORCID: 0000-0003-1080-7425Papers by this author
worksLate outcomes of congenital and childhood non-immune, isolated atrioventricular block: a French nationwide retrospective cohort study
2025 · EP Europace · 5 citations
https://doi.org/10.1093/europace/euaf040
Late outcomes of congenital and childhood non-immune, isolated atrioventricular block: a French nationwide retrospective cohort study
2025 · EP Europace · 5 citations
https://doi.org/10.1093/europace/euaf040
Platelet function and microparticles levels for patients with paroxysmal and persistent atrial fibrillation including during acute episodes
2016 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat